The Valley Desk

NCT02643550 · Interventional trial

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Overall registry status Completed

Phase 1 · Phase 2

Conditions Head and Neck Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov